GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $81,000 | -31.9% | 231,428 | -9.7% | 0.00% | – |
| Q2 2016 | $119,000 | -74.4% | 256,297 | -24.8% | 0.00% | – |
| Q1 2016 | $464,000 | +22.1% | 341,037 | +32.2% | 0.00% | – |
| Q4 2015 | $380,000 | -40.1% | 258,045 | -35.8% | 0.00% | – |
| Q3 2015 | $634,000 | -19.9% | 401,848 | -13.7% | 0.00% | – |
| Q2 2015 | $792,000 | +56.2% | 465,400 | +27.5% | 0.00% | – |
| Q1 2015 | $507,000 | -10.9% | 365,150 | -3.2% | 0.00% | – |
| Q4 2014 | $569,000 | -38.9% | 377,156 | -16.6% | 0.00% | – |
| Q3 2014 | $932,000 | +0.2% | 452,056 | +48.6% | 0.00% | – |
| Q2 2014 | $930,000 | -16.0% | 304,143 | -31.4% | 0.00% | – |
| Q1 2014 | $1,107,000 | -54.0% | 443,263 | -8.7% | 0.00% | -100.0% |
| Q4 2013 | $2,408,000 | +288.4% | 485,417 | +78.7% | 0.00% | – |
| Q3 2013 | $620,000 | -59.6% | 271,648 | -60.7% | 0.00% | -100.0% |
| Q2 2013 | $1,533,000 | – | 690,781 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|